Malaysia GMP Standard
Malaysia regulates medicine manufacture through the Control of Drugs and Cosmetics Regulations 1984, made under the Sale of Drugs Act 1952 and administered by the Drug Control Authority (DCA), for which the National Pharmaceutical Regulatory Agency (NPRA) is the secretariat. Malaysia became the 26th PIC/S participating authority on 1 January 2002, and NPRA adopts the current PIC/S Guide to GMP for Medicinal Products as the standard it uses to assess GMP conformity for local and foreign manufacturers.
What this does not cover
stated in the document's own scope- Adopts the PIC/S GMP Guide rather than a separate Malaysian GMP code.
- Sets manufacturing GMP; product registration is decided by the Drug Control Authority, with NPRA as its secretariat.
- Additional requirements, such as halal certification for certain products, are handled through separate frameworks.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
Malaysia regulates the manufacture of medicines through the Control of Drugs and Cosmetics Regulations 1984, administered by the Drug Control Authority (DCA), for which the National Pharmaceutical Regulatory Agency (NPRA) is the secretariat. NPRA adopts the PIC/S Guide to Good Manufacturing Practice for Medicinal Products as the standard it uses to assess GMP conformity, for both Malaysian sites and the foreign manufacturers of products registered in Malaysia. GMP conformity is a prerequisite for the product registration the DCA grants.
Scope & applicability
Manufacturers of registered products supplying Malaysia, including foreign sites assessed through GMP evidence or inspection. Registration decisions rest with the DCA.
Legal basis & how it acquires force
The Control of Drugs and Cosmetics Regulations 1984 are made under the Sale of Drugs Act 1952 and are binding for the Malaysian market. They require that the standard of manufacture and quality control of registered products be assessed, and NPRA — as the DCA secretariat — carries out that assessment against the adopted PIC/S GMP Guide. Registration decisions rest with the Drug Control Authority; NPRA provides the technical and administrative function that supports them.
Document structure
| Part | Covers |
|---|---|
| Regulatory framework | The Control of Drugs and Cosmetics Regulations 1984 and the role of the Drug Control Authority |
| Adopted GMP standard (PIC/S Part I) | Basic requirements for medicinal products — quality system, personnel, premises, documentation, production, and quality control |
| Adopted GMP standard (PIC/S Part II) | Basic requirements for active substances used as starting materials |
| Foreign GMP conformity | Assessment of overseas manufacturers through acceptable GMP evidence or GMP inspection |
| Annexes | The PIC/S annexes applied to specialised manufacturing operations |
Key requirements
- Conform to the current PIC/S GMP Guide adopted by NPRA.
- Provide acceptable GMP evidence or undergo a GMP inspection for foreign manufacturing sites.
- Support product registration held by the Drug Control Authority with valid GMP status.
Implementation tips
- NPRA can accept GMP certificates and inspection reports from other PIC/S member authorities in lieu of a new inspection.
Revision notes
Malaysia (NPRA/DCA) acceded to PIC/S on 1 January 2002 and adopts the current PIC/S GMP Guide.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
Malaysia became the 26th PIC/S participating authority on 1 January 2002, and NPRA adopts the current PIC/S GMP Guide, so Malaysian GMP is harmonised with the PIC/S membership and, through it, with EU GMP. PIC/S membership lets NPRA accept GMP certificates and inspection reports from other PIC/S member authorities, and from authorities with a cooperation arrangement such as an MRA, in lieu of a fresh inspection.
CDCR 1984 / PIC/S GMP: frequently asked questions
Quick answers to common questions about CDCR 1984 / PIC/S GMP.
Who regulates GMP in Malaysia — NPRA or the DCA?
Both, in defined roles. The Drug Control Authority (DCA) is the decision-making body for registration; the National Pharmaceutical Regulatory Agency (NPRA) is its secretariat and carries out GMP assessment against the adopted PIC/S GMP Guide.
When did Malaysia join PIC/S?
Malaysia became the 26th PIC/S participating authority on 1 January 2002, and NPRA adopts the current PIC/S GMP Guide as its standard.
Does NPRA accept foreign GMP certificates?
Yes. As a PIC/S member, NPRA can accept GMP certificates and inspection reports from other PIC/S member authorities, or from authorities with a cooperation arrangement such as an MRA, instead of conducting a new inspection.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.